Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only.

ABSTRACT:

Purpose

Pancreatic cancer associated double primary tumors are rare and their clinicopathologic characteristics are not well elucidated.

Materials and methods

Clinicopathologic factors of 1,352 primary pancreatic cancers with or without associated double primary tumors were evaluated.

Results

Of resected primary pancreatic cancers, 113 (8.4%) had associated double primary tumors, including 26 stomach, 25 colorectal, 18 lung, and 13 thyroid cancers. The median interval between the diagnoses of pancreatic cancer and associated double primary tumors was 0.5 months. Overall survival (OS) of pancreatic cancer patients with associated double primary tumors was longer than those with pancreatic cancer only (median, 23.1 months vs. 17.0 months, p=0.002). Patients whose pancre

SUBMITTER: Shin SJ 

PROVIDER: S-EPMC6192923 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature